Study Shows Consistent Efficacy, Safety of Inclisiran in Lowering Low-Density Lipoprotein …

In the trials, the most common adverse events (AEs) were diabetes mellitus, hypertension, nasopharyngitis, arthralgia, back pain, dyspnea, bronchitis, …
Source: back pain